Figure 4.
Developmental potential of human embryos following CRISPR-Cas9-mediated genome editing. (A) Developmental comparison of ICSI-CRISPR-generated human embryos against control embryos. POU5F1 edited embryos exhibited increased developmental arrest starting from eight-cell stage. Chi-squared test (P = 0.0439) revealed a significant difference between the developmental rates in CRISPR-ICSI (n = 101) and control embryos (n = 33). (B) Brightfield images of the generated POU5F1-null human blastocysts and the corresponding fragment analysis results, confirming the editing of the targeted locus. (C) Immunofluorescence analysis for POU5F1 (Red), SOX17 (Green), and DAPI (Blue) at 6.5 dpf.

Developmental potential of human embryos following CRISPR-Cas9-mediated genome editing. (A) Developmental comparison of ICSI-CRISPR-generated human embryos against control embryos. POU5F1 edited embryos exhibited increased developmental arrest starting from eight-cell stage. Chi-squared test (P = 0.0439) revealed a significant difference between the developmental rates in CRISPR-ICSI (n = 101) and control embryos (n = 33). (B) Brightfield images of the generated POU5F1-null human blastocysts and the corresponding fragment analysis results, confirming the editing of the targeted locus. (C) Immunofluorescence analysis for POU5F1 (Red), SOX17 (Green), and DAPI (Blue) at 6.5 dpf.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close